Since their entrance to the market in 2003, global use has risen exponentially. In a 2014 survey, about 13% of American high school students reported using them at least once in the previous month, and in 2015 around 10% of American adults were users. In the UK, users have increased from 700,000 in 2012 to 2.6 million in 2015. About 60% of UK users are smokers and about 40% are ex-smokers, while use among never-smokers in the UK is negligible. Most still use traditional cigarettes, raising concern that dual use may "delay or deter quitting". Most peoples' reason for using e-cigarettes involve trying to quit smoking, though a large proportion use them recreationally. It is commonly stated that the modern e-cigarette was invented in 2003 by Chinese pharmacist Hon Lik, but tobacco companies have been developing nicotine aerosol generation devices since as early as 1963. As of 2018[update] most e-cigarettes were made in China. Because of overlap with tobacco laws and medical drug policies, e-cigarette legislation is being debated in many countries. The revised EU Tobacco Products Directive came into effect May 2016, providing regulation for e-cigarettes. As of August 2016, the FDA extended its regulatory power to include e-cigarettes.Large tobacco companies have greatly increased their marketing efforts. As of 2014[update], there were 466 brands of e-cigarettes, with global sales of around $7 billion.
Aerosol (vapor) exhaled by an e-cigarette user using a nicotine-free e-cigarette.
Since their introduction to the market in 2003, global usage of e-cigarettes has risen exponentially. By 2013, there were several million users globally. Awareness and use of e-cigarettes greatly increased over the few years leading up to 2014, particularly among young people and women in some parts of the world. A 2013 four-country survey found there was generally greater awareness among white adult smokers compared with non-white ones. Vaping is increasing in the majority of high-income countries. E-cigarette use in the US and Europe is higher than in other countries, except for China which has the greatest number of e-cigarette users. Growth in the US had reportedly slowed in 2015, lowering market forecasts for 2016. Growth in the UK as of January 2018[update] had reportedly slowed since 2013. The growing frequency of e-cigarette use may be due to heavy promotion in youth-driven media channels, their low cost, and the misbelief that e-cigarettes are safer than traditional cigarettes, according to a 2016 review.
Surveys in 2010 and 2011 suggested that adults with higher incomes were more likely to have heard of e-cigarettes, but those with lower incomes may have been more likely to try them. Most users had a history of smoking regular cigarettes, while results by race were mixed. At least 52% of smokers or ex-smokers have used an e-cigarette. Of smokers who have, less than 15% become everyday e-cigarette users. Though e-cigarette use among those who have never smoked is very low, it continues to rise. Daily vapers are typically recent former smokers. E-cigarettes are commonly used among non-smokers. This includes young adult non-smokers. Vaping is the largest among adults between 18 and 24 years of age, and use is the largest among adults who do not have a high school diploma. Young adults who vape but do not smoke are more than twice as likely to intend to try smoking than their peers who do not vape. A worldwide survey of e-cigarette users conducted in 2014 found that only 3.5% of respondents used liquid without nicotine.
Greater than 10 million people vape daily, as of 2018[update]. Everyday use is common among e-cigarette users. E-cigarette users mostly keep smoking traditional cigarettes. Adults often vape to replace tobacco. Most vapers still use nicotine liquids after stopping smoking for several months. Most e-cigarette users are middle-aged men who also smoke traditional cigarettes, either to help them quit or for recreational use. Older people are more likely to vape for quitting smoking than younger people. Men were found to use higher nicotine doses, compared with women who were vaping. Gender was found to be a predictor of current e-cigarette use with males being significantly more likely to declare having already tried it than females. Among young adults e-cigarette use is not regularly associated with trying to quit smoking. The research indicates that the most common way people try to quit smoking in the UK is with e-cigarettes.
Dual use of e-cigarettes and traditional tobacco is still a definite concern. Dual use of e-cigarettes with cigarettes is the most frequent pattern. One-time e-cigarette use seems to be higher in people with greater levels of educational achievement. Women smokers who are poorer and did not finish high school are more likely to have tried vaping at least once. Vocational school career, lower school performance, being out of school, and studying at a disadvantaged school have been shown to be associated with both e-cigarette ever use and e-cigarette daily use. Vaping is increasing among people with cancer who are frequent smokers.
In the context of drugs, the gateway hypothesis predicts that the use of less deleterious drugs can lead to a future risk of using more dangerous hard drugs or crime. There is wide concern that vaping may be a "gateway" to smoking. Vaping may also act as a gateway to illicit drug use (recreational use of illegal drugs), is an area of concern. Studies indicate vaping serves as a gateway to traditional cigarettes and cannabis use. Under the common liability model, some have suggested that any favorable relation between vaping and starting smoking is a result of common risk factors. This includes impulsive and sensation seekingpersonality types or exposure to people who are sympathetic with smoking and relatives. A 2014 review using animal models found that nicotine exposure may increase the likelihood to using other drugs, independent of factors associated with a common liability.[notes 3] The gateway theory, in relation to using nicotine, has also been used as a way to propose that using tobacco-free nicotine is probably going to lead to using nicotine via tobacco smoking, and therefore that vaping by non-smokers, and especially by children, may result in smoking independent of other factors associated with starting smoking. Some see the gateway model as a way to illustrate the potential risk-heightening effect of vaping and going on to use combusted tobacco products.
There is concern regarding that the accessibility of e-liquid flavors could lead to using additional tobacco products among non-smokers. It is argued to implement the precautionary principle because vaping by non-smokers may lead to smoking. There is a concern with the possibility that non-smokers as well as children may start nicotine use with e-cigarettes at a rate higher than anticipated than if they were never created. In certain cases, e-cigarettes might increase the likelihood of being exposed to nicotine itself, especially for never-nicotine users who start using nicotine products only as a result of these devices. A 2015 review concluded that "Nicotine acts as a gateway drug on the brain, and this effect is likely to occur whether the exposure is from smoking tobacco, passive tobacco smoke or e-cigarettes." Because those with mental illness are highly predisposed to nicotine addiction, those who try e-cigarettes may be more likely to become dependent, raising concerns about facilitating a transition to combustible tobacco use. Even if an e-cigarette contains no nicotine, the user mimics the actions of smoking. This may renormalize tobacco use in the general public. Normalization of e-cigarette use may lead former cigarette smokers to begin using them, thereby reinstating their nicotine dependence and fostering a return to tobacco use.
The "catalyst model" suggests that vaping may proliferate smoking in minors by sensitizing minors to nicotine with the use of a type of nicotine that is more pleasing and without the negative attributes of regular cigarettes. A 2016 review, based on the catalyst model, "indicate that the perceived health risks, specific product characteristics (such as taste, price and inconspicuous use), and higher levels of acceptance among peers and others potentially make e-cigarettes initially more attractive to adolescents than tobacco cigarettes. Later, increasing familiarity with nicotine could lead to the reevaluation of both electronic and tobacco cigarettes and subsequently to a potential transition to tobacco smoking."
E-cigarette use was also rising among women, including women of childbearing age as of 2014[update], but the rate of use during pregnancy is unknown. Many woman still vape during pregnancy because of their perceived safety in comparison with tobacco. In one of the few studies identified, a 2015 survey of 316 pregnant women in a Maryland clinic found that the majority had heard of e-cigarettes, 13% had ever used them, and 0.6% were current daily users. These findings are of concern because the dose of nicotine delivered by e-cigarettes can be as high or higher than that delivered by traditional cigarettes. The rate of e-cigarette use among pregnant adolescents is unknown.
Today, more high school students use e-cigarettes than regular cigarettes. The use of e-cigarettes is higher among high school students than adults.
The prevalence of vaping among adolescents is increasing worldwide. There is substantial variability in vaping in youth worldwide across countries. Over the years leading up to 2017 vaping among adolescents has grown every year since these devices were first introduced to the market. There appears to be an increase of one-time e-cigarette use among young people worldwide. The frequency of vaping in youth is low. The result of youth e-cigarette use leading to smoking is unclear. Most e-cigarette users among youth have never smoked. Many youth who use e-cigarettes also smoke traditional cigarettes. Some youths who have tried an e-cigarette have never used a traditional cigarette; indicating e-cigarettes may be a starting point for nicotine use. Adolescents who would have not been using nicotine products to begin with are vaping. Twice as many youth vaped in 2014 than also used traditional cigarettes. Vaping seems to be a gateway to using traditional cigarettes in adolescents. Youth who use e-cigarettes are more likely to go on to use traditional cigarettes. The evidence suggests that young people who vape are also at greater risk for subsequent long-term tobacco use. E-cigarettes are expanding the nicotine market by attracting low-risk youth who would be unlikely to initiate nicotine use with traditional cigarettes. Data from a longitudinal cohort study of children with alcoholic parents found that adolescents (both middle and late adolescence) who used cigarettes, marijuana, or alcohol were significantly more likely to have ever used e-cigarettes. Adolescents were more likely to initiate vaping through flavored e-cigarettes. Among youth who have ever tried an e-cigarette, a majority used a flavored product the first time they tried an e-cigarette.
Most youth are not vaping to help them quit tobacco. Adolescent vaping is unlikely to be associated with trying to reduce or quit tobacco. Adolescents who vape but do not smoke are more than twice as likely to intend to try smoking than their peers who do not vape. Vaping is correlated with a higher occurrence of cigarette smoking among adolescents, even in those who otherwise may not have been interested in smoking. Adolescence experimenting with e-cigarettes appears to encourage continued use of traditional cigarettes. A 2015 study found minors had little resistance to buying e-cigarettes online. An emerging concern is that nicotine, fruit flavors, and other e-liquid additives could incite teenagers and children to start using traditional cigarettes. Teenagers may not admit using e-cigarettes, but use, for instance, a hookah pen. As a result, self-reporting may be lower in surveys. Experts suggest that candy-like flavors could lead youths to experiment with vaping. E-cigarette advertisements seen by youth could increase the likelihood among youths to experiment with vaping. A 2016 review found "The reasons for the increasing use of e-cigarettes by minors (persons between 12 and 17 years of age) may include robust marketing and advertising campaigns that showcase celebrities, popular activities, evocative images, and appealing flavors, such as cotton candy." A 2014 survey stated that vapers may have less social and behavioral stigma than cigarette smokers, causing concern that vaping products are enticing youth who may not under other circumstances have used these products. The frequency of vaping is higher in adolescent with asthma than in adolescent who do not have asthma. Boys had experimented more often than girls.
There are varied reasons for e-cigarette use. Most users' motivation is related to trying to quit smoking, but a large proportion of use is recreational. Adults cite predominantly three reasons for trying and using e-cigarettes: as an aid to smoking cessation, a belief that they are a safer alternative to traditional cigarettes, and as a way to conveniently get around smoke-free laws. Some users vape for the enjoyment of the activity. Many e-cigarette users use them because they believe they are safer than traditional cigarettes. People who think they pose less risk than cigarette smoking are more likely to vape. A 2017 report found that smokers who previously vaped and quit though continued smoking, 51.5% believed that vaping is less risky than smoking  In contrast, 90% of former-smokers who vape believed vaping as less risky than cigarettes. A 2017 report found that a minority of the respondents believed that replacing cigarettes with e-cigarettes would be helpful for their health. Many users vape because they believe it is healthier than smoking for themselves or bystanders. Usually, only a small proportion of users are concerned about the potential adverse health effects. Some people say they want to quit smoking by vaping, but others vape to circumvent smoke-free laws and policies, or to cut back on cigarette smoking. 56% of respondents in a US 2013 survey had tried vaping to quit or reduce their smoking. In the same survey, 26% of respondents would use them in areas where smoking was banned. Continuing dual use among smokers is correlated with trying to cut down on smoking and to get around smoking bans, increased desire to quit smoking, and a decreased smoking dependence. Seniors seem to vape to quit smoking or to get around smoke‐free policies. Concerns over avoiding stains on teeth or odor from smoke on clothes in some cases prompted interest in or use of e-cigarettes. Some e-cigarettes appeal considerably to people curious in technology who want to customize their devices. There appears to be a hereditary component to tobacco use, which probably plays a part in transitioning of e-cigarette use from experimentation to routine use.
It is conceivable that former smokers may be tempted to use nicotine again as a result of e-cigarettes, and possibly start smoking again. E-liquid flavors are enticing to a range of smokers and non-smokers. Non-smoking adults tried e-cigarettes due to curiosity, because a relative was using them, or because they were given one. College students often vape for experimentation. Millions of dollars spent on marketing aimed at smokers suggests e-cigarettes are "newer, healthier, cheaper and easier to use in smoke-free situations, all reasons that e-cigarette users claim motivate their use". Marketing messages echo well-established cigarette themes, including freedom, good taste, romance, sexuality, and sociability as well as messages stating that e-cigarettes are healthy, are useful for smoking cessation, and can be used in smoke free environments. These messages are mirrored in the reasons that adults and youth cite for using e-cigarettes. Exposure to e-cigarette advertising influences people to try them.
The belief that e-cigarettes are safer than traditional cigarettes could widen their use among pregnant women. If tobacco businesses persuade women that e-cigarettes are a small risk, non-smoking women of reproductive age might start using them and women smoking during pregnancy might switch to their use or use these devices to reduce smoking, instead of quitting smoking altogether. Traditional cigarette users who have not used e-cigarettes had mixed ideas about their possible satisfaction and around a third thought that e-cigarettes might taste bad. Among current e-cigarette users, e-liquid flavor availability is very appealing. They feel or taste similar to traditional cigarettes, and vapers disagree about whether this is a benefit or a drawback. Some users like that e-cigarettes resembled traditional cigarettes, but others did not. E-cigarettes users' views about saving money from using e-cigarettes compared to traditional cigarettes are inconsistent. The majority of committed e-cigarette users interviewed at an e-cigarette convention found them cheaper than traditional cigarettes.
Some users stopped vaping due to issues with the devices. Dissatisfaction and concerns over safety can discourage ongoing e-cigarette use. Commonly reported issues with using e-cigarettes were that the devices were hard to refill, the cartridges might leak and that altering the dose was hard. Smokers mainly quit vaping because it did not feel similar to traditional cigarettes, did not aid with cravings, and because they wanted to use them only to know what they were like.
Many users may begin by using a disposable e-cigarette. Users often start with e-cigarettes resembling traditional cigarettes, eventually moving to a later-generation device. Most later-generation e-cigarette users shifted to their present device to get a "more satisfying hit", and users may adjust their devices to provide more vapor for better "throat hits". A 2014 study reported that experienced users preferred rechargeable e-cigarettes over disposable ones. The most commonly used e-cigarettes in the UK are devices with refillable tanks. Most users used either closed systems or open systems, and rarely used both. Women were found to prefer disposable e-cigarettes, and young adults were found to pay more attention to modifiability. Modifiability also was found to increase the probability of initiating e-cigarettes among adolescents.
A 2013 study found that about three-fourths of smokers used a tank system, which allows users to choose flavors and strength to mix their own liquid. Experienced e-cigarette users even ranked the ability to customize as the most important characteristic. Users ranked nicotine strength as an important factor for choosing among various e-cigarettes, though such preference could vary by smoking status, e-cigarette use history, and gender. Non-smokers and inexperienced e-cigarettes users tended to prefer no nicotine or low nicotine e-cigarettes while smokers and experienced e-cigarettes users preferred medium and high nicotine e-cigarettes. There is an abundance of colors, designs, carrying cases, and accessories to accommodate the diversity in personal preferences.
Exploded view of an e-cigarette with transparent clearomizer and changeable dual-coil head. This model allows for a wide range of settings.
E-cigarettes can come in very different forms—such as this hand-grenade-shaped variant.
An e-cigarette is a handheld battery-powered vaporizer that simulates smoking, but without tobacco combustion. E-cigarette components include a mouthpiece, a cartridge (liquid storage area), a heating element/atomizer, a microprocessor, a battery, and some of them have a LED light on the end. An exception to this are mechanical e-cigarettes (mods) which contain no electronics and the circuit is closed by using a mechanical action switch. An atomizer consists of a small heating element, or coil that vaporizes e-liquid and a wicking material that draws liquid onto the coil. When the user inhales a flow sensor activates the heating element that atomizes the liquid solution; most devices are manually activated by a push-button. The e-liquid reaches a temperature of roughly 100-250 °C (212º-482 °F) within a chamber to create an aerosolized vapor. The user inhales an aerosol, which is commonly but inaccurately called vapor, rather than cigarette smoke. Vaping is different than smoking, but there are some similarities, including the hand-to-mouth action of smoking and a vapor that looks like cigarette smoke. The aerosol provides a flavor and feel similar to smoking. A traditional cigarette is smooth and light but an e-cigarette is rigid, cold and slightly heavier. There is a learning curve to use e-cigarettes properly. E-cigarettes are cigarette-shaped, and there are many other variations. E-cigarettes that resemble pens or USB memory sticks are also sold that may be used unobtrusively.
There are multiple types of e-cigarettes: cigalikes that look like cigarettes; tank models that are bigger than cigalikes and have refillable liquid tanks; and mods, assembled from basic parts or by altering existing products. Cigalikes are either disposable or come with rechargeable batteries and replaceable nicotine cartridges. A cigalike e-cigarette contains a cartomizer, which is connected to a battery. A "cartomizer" (a portmanteau of cartridge and atomizer) or "carto" consists of an atomizer surrounded by a liquid-soaked poly-foam that acts as an e-liquid holder. Clearomizers or "clearos", not unlike cartotanks, use a clear tank in which an atomizer is inserted. A rebuildable atomizer or an RBA is an atomizer that allows the user to assemble or "build" the wick and coil themselves instead of replacing them with off-the-shelf atomizer "heads". The power source is the biggest component of an e-cigarette, which is frequently a rechargeable lithium-ion battery.
As the e-cigarette industry continues to evolve, new products are quickly developed and brought to market. First-generation e-cigarettes tend to look like traditional cigarettes and so are called "cigalikes". Most cigalikes look like cigarettes but there is some variation in size. Second-generation devices are larger overall and look less like traditional cigarettes. Third-generation devices include mechanical mods and variable voltage devices. The fourth-generation includes Sub ohm tanks (meaning that they have electrical resistance of less than 1 Ohm) and temperature control devices. The voltage for first-generation e-cigarettes is about 3.7 and second-generation e-cigarettes can be adjusted from 3 V to 6 V, while more recent devices can go up to 8 V.
E-liquid is the mixture used in vapor products such as e-cigarettes and usually contain propylene glycol, glycerin, nicotine, flavorings, additives, and differing amounts of contaminants. E-liquid formulations greatly vary due to fast growth and changes in manufacturing designs of e-cigarettes. The composition of the e-liquid for additives such as nicotine and flavors vary across and within brands. The liquid typically consists of a combined total of 95% propylene glycol and glycerin, and the remaining 5% being flavorings, nicotine, and other additives. There are e-liquids sold without propylene glycol, nicotine, or flavors. The flavorings may be natural, artificial, or organic. Over 80 chemicals such as formaldehyde and metallic nanoparticles have been found in the e-liquid. There are many e-liquids manufacturers in the US and worldwide, and upwards of 8,000 flavors. Under the US Food and Drug Administration (FDA) rules, e-liquid manufacturers are required to comply with a number of manufacturing standards. The revision to the EU Tobacco Products Directive has some standards for e-liquids. Industry standards have been created and published by the American E-liquid Manufacturing Standards Association (AEMSA).
The scientific community in US and Europe are primarily concerned with their possible effect on public health. There is concern among public health experts that e-cigarettes could renormalize smoking, weaken measures to control tobacco, and serve as a gateway for smoking among youth. The public health community is divided over whether to support e-cigarettes, because their safety and efficacy for quitting smoking is unclear. Many in the public health community acknowledge the potential for their quitting smoking and decreasing harm benefits, but there remains a concern over their long-term safety and potential for a new era of users to get addicted to nicotine and then tobacco. There is concern among tobacco control academics and advocates that prevalent universal vaping "will bring its own distinct but as yet unknown health risks in the same way tobacco smoking did, as a result of chronic exposure", among other things.
Medical organizations differ in their views about the health implications of vaping. There is general agreement that e-cigarettes expose users to fewer toxicants than tobacco cigarettes. Some healthcare groups and policy makers have hesitated to recommend e-cigarettes for quitting smoking, because of limited evidence of effectiveness and safety. Some have advocated bans on e-cigarette sales and others have suggested that e-cigarettes may be regulated as tobacco products but with less nicotine content or be regulated as a medicinal product. A 2016 World Health Organization (WHO) report found that the scientific evidence for the effectiveness of vaping for quitting smoking is "scant and of low certainty". Healthcare organizations in the UK in 2015 have encouraged smokers to try e-cigarettes to help them quit smoking and also encouraged e-cigarette users to quit smoking tobacco entirely. In 2016, the US Food and Drug Administration (FDA) stated that "Although ENDS [electronic nicotine delivery systems] may potentially provide cessation benefits to individual smokers, no ENDS have been approved as effective cessation aids." In 2019 the European Respiratory Society stated that "The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term."
CDC launches "Tips From Former Smokers" ad campaign in 2015. The main information on e-cigarettes begins at 24:45.
The available research on the safety and efficacy of e-cigarette use for smoking cessation is limited. Data regarding their use includes four randomized controlled trials and a number of user surveys, case reports, and cohort studies. Some research indicates benefits for their use, whereas other evidence cited harms. Their use for quitting smoking is controversial. Studies determining whether e-cigarettes can help as a smoking cessation aid have come to different conclusions. The evidence is conflicting to support or dismiss vaping for quit smoking. As a result of the data being confronted with methodological and study design limitations, no firm conclusions can be drawn in respect to their efficacy and safety. It is difficult to reach a general conclusion from e-cigarette use for smoking cessation because there are hundreds of brands and models of e-cigarettes sold that vary in the composition of the liquid. E-cigarettes have not been subjected to the same type of efficacy testing as nicotine replacement products. No long-term trials have been conducted for their use as a smoking cessation aid. E-cigarette use may decrease the number of cigarettes smoked, but smoking just one to four cigarettes daily greatly increases the risk of cardiovascular disease. The health benefits of reducing cigarette use while vaping is unclear. The extent to which descreasing cigarette smoking with vaping leads to quitting is unknown. Whether or not vaping is potentially effective for quitting smoking may rely upon whether it was used as part of making an effort to quit or not. It is still not evident as to whether vaping can adequately assist with quitting smoking at the population level. A 2015 PHE report recommends for smokers who cannot or do not want to quit to use e-cigarettes as one of the main steps to lower smoking-related disease, while a 2015 US PSTF statement found there is not enough evidence to recommend e-cigarettes for quitting smoking in adults, pregnant women, and adolescents.
There is tentative evidence they may help people quit smoking, and studies pertaining to their potential impact on smoking cessation and reduction are very limited. Randomized controlled trials have not shown that vaping is effective for quitting smoking. A 2016 meta-analysis based on 20 different studies found that smokers who used e-cigarettes were 28% less likely to quit than those who had not tried e-cigarettes. This finding persisted whether not the smokers where initially interested in quitting or not. A 2015 meta-analysis on clinical trials found that e-cigarettes containing nicotine are more effective than nicotine-free ones for quitting smoking. They compared their finding that nicotine-containing e-cigarettes helped 20% of people quit with the results from other studies that found nicotine replacement products helps 10% of people quit. A 2016 review found low quality evidence of a trend towards benefit of e-cigarettes with nicotine for smoking cessation. Low quality evidence suggests e-cigarettes may be of a benefit for some smokers to stop or cut back on smoking. A 2016 review found that the combined abstinence rate among smokers using e-cigarettes in prospective studies was 29.1%. The same review noted that few clinical trials and prospective studies had yet been conducted on their effectiveness, and only one randomized clinical trial had included a group using other quit smoking methods. It is unclear whether e-cigarettes are only helpful for particular types of smokers. Vaping with nicotine may reduce tobacco use among daily smokers. Their similarity of vapor looking like cigarette smoke may prolong traditional cigarette use for people who could have quit instead, but the growing support of e-cigarettes could put extra pressure on smokers to stop cigarette smoking because smoking may be seen as socially unacceptable compared to a smokeless e-cigarette. The efficacy and safety of vaping for quitting smoking during pregnancy is unknown. No research is available to provide details on the efficacy of vaping for quitting smoking during pregnancy. There is robust evidence that vaping is not effective for quitting smoking among adolescents. In view of the shortage of evidence, vaping is not recommend for cancer patients. The effectiveness of vaping for quitting smoking among vulnerable groups is uncertain.
Vaping is not clearly more or less effective than regulated nicotine replacement products or 'usual care' for quitting smoking. The available research suggests e-cigarettes are likely equal or slightly better than nicotine patches for quitting smoking. People who vaped were not more likely to give up smoking than people who did not vape. Compared to many alternative quitting smoking medicines in early development in clinical trials including e-cigarettes, cytisine appears to be most encouraging in efﬁcacy and safety with an inexpensive price. E-cigarettes have not been proven to be more effective than smoking cessation medicine and regulated FDA medicine. A 2014 review recommends to first try regulated treatments. A 2014 review found they may be as effective, but not more, compared to nicotine patches for short-term quitting smoking. They also found that a randomized trial stated 29% of e-cigarette users were still vaping at 6 months, while only 8% of patch users still wore patches at 6 months. Some individuals who quit smoking with a vaping device are continuing to vape after a year. Vaping appears to be as effective as nicotine replacement products, though its potential adverse effects such as normalizing smoking have not been adequately studied. While some surveys reported improved quitting smoking, particularly with intensive e-cigarette users, several studies showed a decline in quitting smoking in dual users. Other kinds of nicotine replacement products are usually covered by health systems, but because e-cigarettes are not medically licensed they are not covered. In terms of whether flavored e-cigarettes assisted quitting smoking, the evidence is inconclusive.
As of January 2018[update], systematic reviews collectively agreed that there is insufficient evidence to unequivocally determine whether vaping helped people abstain from smoking. A 2015 overview of systematic reviews indicates that e-cigarettes has no benefit for smokers trying to quit, and that the high rate of dual use indicates that e-cigarettes are used for supporting their nicotine addiction. The evidence indicates smokers are more frequently able to completely quit smoking using tank devices compared to cigalikes, which may be due to their more efficient nicotine delivery. There is low quality evidence that vaping assists smokers to quit smoking in the long-term compared with nicotine-free vaping. Nicotine-containing e-cigarettes were associated with greater effectiveness for quitting smoking than e-cigarettes without nicotine. A 2013 study in smokers who were not trying to quit, found that vaping, with or without nicotine decreased the number of cigarettes consumed. E-cigarettes without nicotine may reduce tobacco cravings because of the smoking-related physical stimuli.
The term harm reduction implies any reduction in relative harm from a prior level, even a small reduction such as reducing smoking by one or two cigarettes per day. Harm minimization strives to reduce harms to zero (i.e., ideally to no use and thus no harmful exposure). When a consumer does not want to stop all nicotine use, then harm minimization implies striving for the complete elimination of smoked tobacco exposure by substituting it with the use of less harmful noncombusted forms of nicotine instead of smoking.Tobacco harm reduction (THR) may serve as a substitute for traditional cigarettes with lower risk products to reduce tobacco-related death and disease. Tobacco harm reduction has been a controversial area of tobacco control. Health advocates have been slow to support a harm reduction method out of concern that tobacco companies cannot be trusted to sell products that will lower the risks associated with tobacco use. E-cigarettes can reduce smokers' exposure to carcinogens and other toxic chemicals found in tobacco. A large number of smokers want to reduce harm from smoking by using e-cigarettes. The argument for harm reduction does not take into account the adverse effects of nicotine. There cannot be a defensible reason for harm reduction in children who are vaping with a base of nicotine. Quitting smoking is the most eﬀective strategy to tobacco harm reduction.
Tobacco smoke contains 100 known carcinogens, and 900 potentially cancer causing chemicals, none of which were found in more than trace quantities in the cartridges or aerosol of e-cigarettes back in 2011. But a study in 2015 using a third-generation device found levels of formaldehyde were greater than with cigarette smoke when adjusted to a maximum power setting. E-cigarettes cannot be considered safe because there is no safe level for carcinogens. Due to their similarity to traditional cigarettes, e-cigarettes could play a valuable role in tobacco harm reduction. However, the public health community remains divided concerning the appropriateness of endorsing a device whose safety and efficacy for smoking cessation remain unclear. Overall, the available evidence supports the cautionary implementation of harm reduction interventions aimed at promoting e-cigarettes as attractive and competitive alternatives to cigarette smoking, while taking measures to protect vulnerable groups and individuals.
The core concern is that smokers who could have quit entirely will develop an alternative nicotine addiction. Dual use may be an increased risk to a smoker who continues to use even a minimal amount of traditional cigarettes, rather than quitting. The promotion of vaping as a harm reduction aid is premature, while a 2011 review found they appear to have the potential to lower tobacco-related death and disease. Evidence to substantiate the potential of vaping to lower tobacco-related death and disease is unknown. E-cigarettes could have an influential role in tobacco harm reduction. A 2013 review found that vaping is probably much less harmful to users or bystanders than cigarette smoking. The authors warned against the potential harm of excessive regulation and advised health professionals to consider advising smokers who are reluctant to quit by other methods to switch to e-cigarettes as a safer alternative to smoking. A 2015 PHE report concluded that e-cigarette use "releases negligible levels of nicotine into ambient air with no identified health risks to bystanders". A 2014 review recommended that regulations for e-cigarettes could be similar to those for dietary supplements or cosmetic products to not limit their potential for harm reduction. A 2012 review found e-cigarettes could considerably reduce traditional cigarettes use and they likely could be used as a lower risk replacement for traditional cigarettes, but there is not enough data on their safety and efficacy to draw definite conclusions. There is no research available on vaping for reducing harm in high-risk groups such as people with mental disorders.
A 2014 PHE report concluded that hazards associated with products currently on the market are probably low, and apparently much lower than smoking. However, harms could be reduced further through reasonable product standards. The British Medical Association encourages health professionals to recommend conventional nicotine replacement therapies, but for patients unwilling to use or continue using such methods, health professionals may present e-cigarettes as a lower-risk option than tobacco smoking. The American Association of Public Health Physicians (AAPHP) suggests those who are unwilling to quit tobacco smoking or unable to quit with medical advice and pharmaceutical methods should consider other nicotine containing products such as e-cigarettes and smokeless tobacco for long-term use instead of smoking. In an interview, the director of the Office on Smoking and Health for the US federal agency CDC believes that there is enough evidence to say that using e-cigarettes is likely less harmful than smoking traditional cigarettes. However, due to the lack of regulation of the contents of e-cigarettes and the presence of nicotine, the CDC has issued warnings. A 2014 WHO report concluded that some smokers will switch completely to e-cigarettes from traditional tobacco but a "sizeable" number will use both. This report found that such "dual use" of e-cigarettes and tobacco "will have much smaller beneficial effects on overall survival compared with quitting smoking completely."
The risks of e-cigarette use are uncertain. There is little data about their safety, and considerable variation among e-cigarettes and in their liquid ingredients and thus the contents of the aerosol delivered to the user. Reviews on the safety of e-cigarettes have reached significantly different conclusions. A 2014 WHO report cautioned about potential risks of using e-cigarettes. Regulated FDA products such as nicotine inhalers may be safer than e-cigarettes, but e-cigarettes are generally seen as safer than combusted tobacco products such as cigarettes and cigars. It is estimated their safety risk is similar to that of smokeless tobacco, which has about 1% of the mortality risk of traditional cigarettes. A systematic review suggests that e-cigarettes are less harmful than smoking and since they contain no tobacco and do not involve combustion, users may avoid several harmful constituents usually found in tobacco smoke, such as ash, tar, and carbon monoxide. However, e-cigarettes cannot be considered harmless. Repeated exposure over a long time to e-cigarette vapor poses substantial potential risk.
The long-term effects of e-cigarette use are unknown. The risk from serious adverse events, including death, is low. Less serious adverse effects include abdominal pain, headache, blurry vision, throat and mouth irritation, vomiting, nausea, and coughing. They may produce less adverse effects compared to tobacco products. E-cigarettes reduce lung function, but to a much lower extent than with traditional cigarettes, and they reduce cardiac muscle function and increase inflammation, but these changes were only substantial with traditional cigarettes. A 2014 WHO report said, "ENDS [Electronic nicotine delivery system] use poses serious threats to adolescents and fetuses." Aside from toxicity exposure in normal use, there are also risks from misuse or accidents such as nicotine poisoning (especially among small children), contact with liquid nicotine, fires caused by vaporizer malfunction, and explosions resulting from extended charging, unsuitable chargers, or design flaws. Battery explosions are caused by an increase in internal battery temperature and some have resulted in severe skin burns. There is a small risk of battery explosion in devices modified to increase battery power.
The cytotoxicity of e-liquids varies, and contamination with various chemicals have been detected in the liquid. Metal parts of e-cigarettes in contact with the e-liquid can contaminate it with metal particles. Many chemicals including carbonyl compounds such as formaldehyde can inadvertently be produced when the nichrome wire (heating element) that touches the e-liquid is heated and chemically reacted with the liquid. Normal usage of e-cigarettes, and reduced voltage (3.0 V) devices generate very low levels of formaldehyde. The later-generation and "tank-style" e-cigarettes with a higher voltage (5.0 V) may generate equal or higher levels of formaldehyde compared to smoking. A 2015 PHE report found that high levels of formaldehyde only occurred in overheated "dry-puffing". Users detect the "dry puff" (also known as a "dry hit") and avoid it, and they concluded that "There is no indication that EC users are exposed to dangerous levels of aldehydes." However, e-cigarette users may "learn" to overcome the unpleasant taste due to elevated aldehyde formation, when the nicotine craving is high enough. E-cigarette users who use devices that contain nicotine are exposed to its potentially harmful effects. Nicotine is associated with cardiovascular disease, possible birth defects, and poisoning.In vitro studies of nicotine have associated it with cancer, but carcinogenicity has not been demonstrated in vivo. There is inadequate research to show that nicotine is associated with cancer in humans. The risk is probably low from the inhalation of propylene glycol and glycerin. No information is available on the long-term effects of the inhalation of flavors.
E-cigarette device explodes in man's pocket while on bus in California.
E-cigarettes create vapor that consists of fine and ultrafine particles of particulate matter, with the majority of particles in the ultrafine range. The vapor have been found to contain propylene glycol, glycerin, nicotine, flavors, tiny amounts of toxicants,carcinogens,heavy metals, and metal nanoparticles, and other substances. Exactly what the vapor consists of varies in composition and concentration across and within manufacturers, and depends on the contents of the liquid, the physical and electrical design of the device, and user behavior, among other factors. E-cigarette vapor potentially contains harmful chemicals not found in tobacco smoke. The majority of toxic chemicals found in cigarette smoke are absent in e-cigarette vapor. E-cigarette vapor contains lower concentrations of potentially toxic chemicals than with cigarette smoke. Those which are present, are mostly below 1% of the corresponding levels permissible by workplace safety standards. But workplace safety standards do not recognize exposure to certain vulnerable groups such as people with medical ailments, children, and infants who may be exposed to second-hand vapor. Concern exists that some of the mainstream vapor exhaled by e-cigarette users may be inhaled by bystanders, particularly indoors. E-cigarette use by a parent might lead to inadvertent health risks to offspring. A 2014 review recommended that e-cigarettes should be regulated for consumer safety. There is limited information available on the environmental issues around production, use, and disposal of e-cigarettes that use cartridges. E-cigarettes that are not reusable may contribute to the problem of electrical waste.
Human and animal studies have found that nicotine exposure from e-cigarettes during adolescence adversely affects cognitive development, and animal research suggests that it has more severe impacts on the most vulnerable parts of the brain. One such region adversely affected by nicotine within the adolescent brain is the limbic system, which modulates drug reward, cognition, and emotion. Exposure to nicotine during adolescence has also been related to changes in neural circuits, including impairing the development of the prefrontal cortex, which governs judgement and impulse control. Consequently, brain chemistry and neurobehavior is adversely influenced by nicotine exposure.
The rise in the use of e-cigarettes has raised concerns over nicotine overdoses, especially from young children ingesting e-liquids.<McNeill201576 /> Nicotine is poisonous, and e-cigarette use or misuse can lead to nicotine poisoning via ingestion, inhalation, or absorption of nicotine via the skin or eyes, especially for young children. However, 92.5% of exposures to American children were through ingestion.[unreliable medical source?] The risk of accidental nicotine exposure from e-cigarettes is most severe in children under age 6, who have a lower median lethal dose than adolescents or adults,[unreliable medical source?] and it is worst for 1-year-olds.[unreliable medical source?] Early signs of accidental nicotine exposure include quickened heart rate (tachycardia), sweating (diaphoresis), nausea, and vomiting, late effects include low blood pressure (hypotension) and reduced breathing (respiratory depression or hypoventilation), and rare effects include coma, seizure, sustained inability to breath (respiratory arrest), heart attack, and death.[unreliable medical source?] Two children in the US[unreliable medical source?] and four adults in the US and Europe have died from ingesting liquid nicotine. A 2015 Public Health England report also noted an "unconfirmed newspaper report of a fatal poisoning of a two-year old child" in the UK and two reports of children of similar age who had recovered after ingesting e-liquid and vomiting. They noted case reports of suicides by nicotine. Adults have recovered from drinking e-liquid containing up to 1,500 mg of nicotine (helped by vomiting), but an ingestion of about 10,000 mg was fatal, as was an injection. The report commented that "serious nicotine poisoning seems normally prevented by the fact that relatively low doses of nicotine cause nausea and vomiting, which stops users from further intake."
As the usage of e-cigarettes increased between 2012 and 2015, the accidental nicotine exposure rate in the US increased by 1398.2%.[unreliable medical source?] In December 2014 for instance, e-cigarette sales in the US were roughly equivalent to just 3.5% of traditional cigarette sales, but e-cigarettes represented 44% of all e-cigarette and traditional cigarette calls to US poison control centers. The accidental nicotine exposure rate in the US has since decreased by 18.9% between July 2016, when the Child Nicotine Poisoning Prevention Act of 2015, a federal law requiring child-resistant packaging for e-liquid, came into effect, and April 2017.[unreliable medical source?] According to a regression discontinuity design study by Govindarajan et al. (2018), the 32 states without a preexisting law similar to the Child Nicotine Poisoning Prevention Act experienced a significant drop in the average number of exposures during the 9 months before the Act went into effect compared with the 9 months after.[unreliable medical source?] The FDA recommends that e-cigarettes and e-liquids be kept in a safe place, where children and pets do not have access to them. In addition to lack of child-resistant packaging, other factors that the FDA and CDC have attributed to the rise in child ingestion of e-liquid are misbranded sweet e-liquids. Misbranded e-liquids are often sold in packaging that resembles kid-friendly foods, beverages, or candies. Some e-liquids are sold in packaging closely resembling Tree Top-brand juice boxes, Reddi-wip whipped cream, or Sour Patch Kids gummy candy, for example, and children have accidentally drunk these misbranded e-liquids and become sick.
The World Health Organization's view regarding second hand aerosol (SHA) is "that while there are a limited number of studies in this area, it can be concluded that SHA is a new air contamination source for particulate matter, which includes fine and ultrafine particles, as well as 1,2-propanediol, some VOCs [volatile organic compounds], some heavy metals, and nicotine" and "[i]t is nevertheless reasonable to assume that the increased concentration of toxicants from SHA over background levels poses an increased risk for the health of all bystanders". Public Health England has concluded that "international peer-reviewed evidence indicates that the risk to the health of bystanders from secondhand e-cigarette vapor is extremely low and insufficient to justify prohibiting e-cigarettes". A systematic review concluded, "the absolute impact from passive exposure to EC [electronic cigarette] vapor has the potential to lead to adverse health effects. The risk from being passively exposed to EC vapor is likely to be less than the risk from passive exposure to conventional cigarette smoke."
Nicotine, a key ingredient in most e-liquids,[notes 4] is a highly addictive substance, on a level comparable to heroin and cocaine. Addiction is believed to be a disorder of experience-dependent brain plasticity. The reinforcing effects of nicotine play a significant role in the beginning and continuing use of the drug. First-time nicotine users develop a dependence about 32% of the time. Chronic nicotine use involves both psychological and physical dependence. Nicotine-containing e-cigarette vapor induces addiction-related neurochemical, physiological and behavioral changes. Nicotine affects neurological, neuromuscular, cardiovascular, respiratory, immunological and gastrointestinal systems.Neuroplasticity within the brain's reward system occurs as a result of long-term nicotine use, leading to nicotine dependence. The neurophysiological activities that are the basis of nicotine dependence are intricate. It includes genetic components, age, gender, and the environment. Pre-existing cognitive and mood disorders may influence the development and maintenance of nicotine dependence. Nicotine addiction is a disorder which alters different neural systems such as dopaminergic, glutamatergic, GABAergic, serotoninergic, that take part in reacting to nicotine. Long-term nicotine use affects a broad range of genes associated with neurotransmission, signal transduction, and synaptic architecture. The most well-known hereditary influence related to nicotine dependence is a mutation at rs16969968 in the nicotinic acetylcholine receptor CHRNA5, resulting in an amino acid alteration from aspartic acid to asparagine. The single-nucleotide polymorphisms (SNPs) rs6474413 and rs10958726 in CHRNB3 are highly correlated with nicotine dependence. Many other known variants within the CHRNB3–CHRNA6 nicotinic acetylcholine receptors are also correlated with nicotine dependence in certain ethnic groups. There is a relationship between CHRNA5-CHRNA3-CHRNB4 nicotinic acetylcholine receptors and complete smoking cessation. Increasing evidence indicates that the genetic variant CHRNA5 predicts the response to smoking cessation medicine. The ability to quitting smoking is affected by genetic factors, including genetically based differences in the way nicotine is metabolized. In the CYP450 system there are 173 genetic variants, which impacts how quickly nicotine is metabolizes by each individual. The speed of metabolism impacts the regularity and quantity of nicotine used. For instance, in people who metabolize nicotine gradually their central nervous system effects of nicotine lasts longer, increasing their probability of dependence, but also increasing ability with quitting smoking.
The reinforcing effects of drugs of abuse, such as nicotine, are associated with its ability to excite the mesolimbic and dopaminergic systems. How does the nicotine in e-cigarettes affect the brain? Until about age 25, the brain is still growing. Each time a new memory is created or a new skill is learned, stronger connections – or synapses – are built between brain cells. Young people's brains build synapses faster than adult brains. Because addiction is a form of learning, adolescents can get addicted more easily than adults. The nicotine in e-cigarettes and other tobacco products can also prime the adolescent brain for addiction to other drugs such as cocaine.
When nicotine intake stops, the upregulated nicotinic acetylcholine receptors induce withdrawal symptoms. These symptoms can include cravings for nicotine, anger, irritability, anxiety, depression, impatience, trouble sleeping, restlessness, hunger, weight gain, and difficulty concentrating. When trying to quit smoking with vaping a base containing nicotine, symptoms of withdrawal can include irritability, restlessness, poor concentration, anxiety, depression, and hunger. The changes in the brain cause a nicotine user to feel abnormal when not using nicotine. In order to feel normal, the user has to keep his or her body supplied with nicotine. E-cigarettes may reduce cigarette craving and withdrawal symptoms. Lessoning tobacco use via campaigns that portray cigarette smoking as unacceptable and harmful have been enacted, though, advocating for the use of e-cigarettes jeopardizes this with the chance of increasing nicotine addiction. It is not clear whether e-cigarette use will decrease or increase overall nicotine addiction, but the nicotine content in e-cigarettes is adequate to sustain nicotine dependence. Chronic nicotine use causes a broad range of neuroplastic adaptations, making quitting hard to accomplish. A 2015 study found that users vaping non-nicotine e-liquid exhibited signs of dependence. Experienced users tend to take longer puffs which may result in higher nicotine intake. It is difficult to assess the impact of nicotine dependence from e-cigarette use because of the wide range of e-cigarette products. The addiction potential of e-cigarettes may have risen because as they have progressed, they delivery nicotine better.
A 2015 American Academy of Pediatrics (AAP) policy statement stressed "the potential for these products to addict a new generation of youth to nicotine and reverse more than 50 years of public health gains in tobacco control." The World Health Organization (WHO) is concerned about starting nicotine use among non-smokers, and the National Institute on Drug Abuse said e-cigarettes could maintain nicotine addiction in those who are attempting to quit. The limited available data suggests that the likelihood of abuse from e-cigarettes is smaller than traditional cigarettes. A 2014 systematic review found that the concerns that e-cigarettes could lead non-smokers to start smoking are unsubstantiated. No long-term studies have been done on the effectiveness of e-cigarettes in treating tobacco addiction, but some evidence suggests that dual use of e-cigarettes and traditional cigarettes may be associated with greater nicotine dependence.
E-cigarettes use by children and adolescents may result in nicotine addiction.:C:A Following the possibility of nicotine addiction via e-cigarettes, there is concern that children may start smoking cigarettes. Adolescents usually discount nicotine's addictive nature. Vulnerability to the brain-modifying effects of nicotine, along with youthful experimentation with e-cigarettes, could lead to a lifelong addiction. A long-term nicotine addiction from vaping may result in using other tobacco products. The majority of addiction to nicotine starts during youth and young adulthood. Adolescents are more likely to become nicotine dependent than adults. Nicotine has more favorable effects and less adverse effects in adolescents than adults. The adolescent brain seems to be particularly sensitive to neuroplasticity as a result of nicotine. Minimal exposure could be enough to produce neuroplastic alterations in the very sensitive adolescent brain. Exposure to nicotine during adolescence may increase vulnerability to getting addicted to cocaine and other drugs. The ability of e-cigarettes to deliver comparable or higher amounts of nicotine compared to traditional cigarettes raises concerns about e-cigarette use generating nicotine dependence among young people. Youth who believe they are vaping without nicotine could still be inhaling nicotine because there are significant differences between stated and true nicotine content.
Various organizations, including the International Union Against Tuberculosis and Lung Disease, the AAP, the American Cancer Society, the CDC, and the FDA, have expressed concern that e-cigarette use could increase the prevalence of nicotine addiction in youth.:IUATLD:AAP:ACS:CDC:FDA Flavored tobacco is especially enticing to youth, and certain flavored tobacco products increase addiction. There is concern that flavored e-cigarettes could have a similar impact on youth. A 2014 review found no evidence that they are used regularly by those who have never smoked, while another 2014 review has found that in studies up to a third of youth who have not tried a traditional cigarette have used e-cigarettes. The degree to which teens are using e-cigarettes in ways the manufacturers did not intend, such as increasing the nicotine delivery, is unknown, as is the extent to which e-cigarette use may lead to addiction or substance dependence in youth.
In 1927, Joseph Robinson applied for a patent for an electronic vaporizer. Its purpose was to be used with medicinal compounds. The patent was approved in 1930. The device was never made available for sale. In 1930, the United States Patent and Trademark Office reported a patent stating, "for holding medicinal compounds which are electrically or otherwise heated to produce vapors for inhalation." In 1934, a patent stated that a product was "adapted for transforming volatile liquid medicaments into vapors or into mists of exceedingly fine particles." In 1936, a comparable patent was reported. These instances are in regard to vaporization for medicinal use. The earliest e-cigarette can be traced to American Herbert A. Gilbert, who in 1963 patented "a smokeless non-tobacco cigarette" that involved "replacing burning tobacco and paper with heated, moist, flavored air". This device produced flavored steam without nicotine. The patent was granted in 1965. Gilbert's invention was ahead of its time. There were prototypes, but it received little attention and was never commercialized because smoking was still fashionable at that time. Gilbert said in 2013 that today's electric cigarettes follow the basic design set forth in his original patent. The Favor cigarette, introduced in 1986, was another early noncombustible product promoted as an alternative nicotine-containing tobacco product.
Hon Lik, a Chinese pharmacist and inventor, who worked as a research pharmacist for a company producing ginseng products, is frequently credited with the invention of the modern e-cigarette. But tobacco companies have been developing nicotine aerosol generation devices since as early as 1963. Philip Morris' division NuMark, launched in 2013 the MarkTen e-cigarette that Philip Morris had been working on since 1990, 13 years prior to Hon Lik creating his e-cigarette. Lik quit smoking after his father, also a heavy smoker, died of lung cancer. In 2001, he thought of using a high frequency, piezoelectricultrasound-emitting element to vaporize a pressurized jet of liquid containing nicotine. This design creates a smoke-like vapor. Lik said that using resistance heating obtained better results and the difficulty was to scale down the device to a small enough size. Lik's invention was intended to be an alternative to smoking. Hon Lik sees the e-cigarette as comparable to the "digital camera taking over from the analogue camera."
The Ruyan e-cigar was first launched in China in 2004.
Hon Lik registered a patent for the modern e-cigarette design in 2003. Lik is credited with developing the first commercially successful electronic cigarette. The e-cigarette was first introduced to the Chinese domestic market in 2004. Many versions made their way to the US, sold mostly over the Internet by small marketing firms. E-cigarettes entered the European market and the US market in 2006 and 2007. The company that Lik worked for, Golden Dragon Holdings, registered an international patent in November 2007. The company changed its name to Ruyan (如烟, literally "like smoke") later the same month, and started exporting its products. Many US and Chinese e-cigarette makers copied his designs illegally, so Lik has not received much financial reward for his invention (although some US manufacturers have compensated him through out of court settlements). Ruyan later changed its company name to Dragonite International Limited. Most e-cigarettes today use a battery-powered heating element rather than the earlier ultrasonic technology design.
Initially, their performance did not meet the expectations of users. The e-cigarette continued to evolve from the first-generation three-part device. In 2007 British entrepreneurs Umer and Tariq Sheikh invented the cartomizer. This is a mechanism that integrates the heating coil into the liquid chamber. They launched this new device in the UK in 2008 under their Gamucci brand and the design is now widely adopted by most "cigalike" brands. Other users tinkered with various parts to produce more satisfactory homemade devices, and the hobby of "modding" was born. The first mod to replace the e-cigarette's case to accommodate a longer-lasting battery, dubbed the "screwdriver", was developed by Ted and Matt Rogers in 2008. Other enthusiasts built their own mods to improve functionality or aesthetics. When pictures of mods appeared at online vaping forums many people wanted them, so some mod makers produced more for sale.
In 2008, a consumer created an e-cigarette called the screwdriver. The device generated a lot of interest back then, as it let the user to vape for hours at one time. The invention led to demand for customizable e-cigarettes, prompting manufacturers to produce devices with interchangeable components that could be selected by the user. In 2009, Joyetech developed the eGo series which offered the power of the screwdriver model and a user-activated switch to a wide market. The clearomizer was invented in 2009. Originating from the cartomizer design, it contained the wicking material, an e-liquid chamber, and an atomizer coil within a single clear component. The clearomizer allows the user to monitor the liquid level in the device. Soon after the clearomizer reached the market, replaceable atomizer coils and variable voltage batteries were introduced. Clearomizers and eGo batteries became the best-selling customizable e-cigarette components in early 2012.
Large tobacco companies have acquired some of the e-cigarette companies.
International tobacco companies dismissed e-cigarettes as a fad at first. However, recognizing the development of a potential new market sector that could render traditional tobacco products obsolete, they began to produce and market their own brands of e-cigarettes and acquire existing e-cigarette companies. They bought the largest e-cigarette companies.blu eCigs, a prominent US e-cigarette manufacturer, was acquired by Lorillard Inc. for $135 million in April 2012.British American Tobacco was the first tobacco business to sell e-cigarettes in the UK. They launched the e-cigarette Vype in July 2013. They launched Vype in 2013, while Imperial Tobacco's Fontem Ventures acquired the intellectual property owned by Hon Lik through Dragonite International Limited for $US 75 million in 2013 and launched Puritane in partnership with Boots UK. On 1 October 2013 Lorillard Inc. acquired another e-cigarette company, this time the UK based company SKYCIG. SKY was rebranded as blu. On 3 February 2014, Altria Group, Inc. acquired popular e-cigarette brand Green Smoke for $110 million. The deal was finalized in April 2014 for $110 million with $20 million in incentive payments. Altria also markets its own e-cigarette, the MarkTen, while Reynolds American has entered the sector with its Vuse product. Philip Morris, the world's largest tobacco company, purchased UK's Nicocigs in June 2014. On 30 April 2015, Japan Tobacco bought the US Logic e-cigarette brand. Japan Tobacco also bought the UK E-Lites brand in June 2014. On 15 July 15, 2014, Lorillard sold blu to Imperial Tobacco as part of a deal for $7.1 billion.
In 2014, dollar sales of customizable e-cigarettes and e-liquid surpassed sales of cigalikes in the US, even though, overall, customizables are a less expensive vaping option.
Society and culture
Consumers of e-cigarettes have shown passionate support for e-cigarettes that other nicotine replacement products did not receive. They have the potential mass appeal that could challenge combustible tobacco's market position.
A subculture has emerged which calls itself "the vaping community". Members of this emerging subculture often see e-cigarettes as a safer alternative to smoking, and some view it as a hobby. The online forum E-Cig-Reviews.com was one of the first major communities. It and other online forums, such as UKVaper.org, were the origins of the hobby of modding. There are also groups on Facebook and Reddit. Online forums based around modding have grown in the vaping community. Vapers energetically embrace activities associated with e-cigarettes and in some circumstances act as unpaid evangelicals, according to a 2011 study. E-cigarette companies have a substantial online presence, as well as many individual vapers who blog and tweet about e-cigarette related products. A 2014 Postgraduate Medical Journal editorial stated that vapers "also engage in grossly offensive online attacks on anyone who has the temerity to suggest that ENDS are anything other than an innovation that can save thousands of lives with no risks". Contempt for Big Tobacco is part of vaping culture. A 2014 review stated that tobacco and e-cigarette companies interact with consumers for their policy agenda. The companies use websites, social media, and marketing to get consumers involved in opposing bills that include e-cigarettes in smoke-free laws. This is similar to tobacco industry activity going back to the 1980s. These approaches were used in Europe to minimize the EU Tobacco Products Directive in October 2013.Grassroots lobbying also influenced the Tobacco Products Directive decision. Tobacco companies have worked with organizations conceived to promote e-cigarette use, and these organizations have worked to hamper legislation intended at restricting e-cigarette use.
A popular vaporizer used by American youth is the Juul. Close to 80% of respondents in a 2017 Truth Initiative study aged 15–24 reported using Juul also used the device in the last 30 days. Teenagers use the verb "Juuling" to describe their use of Juul, and Juuling is the subject of many memes on social media. Students commented on Twitter about using the Juul device in class.
E-cigarette user blowing a cloud of aerosol (vapor). The activity is known as cloud-chasing.
Large gatherings of vapers, called vape meets, take place around the US. They focus on e-cigarette devices, accessories, and the lifestyle that accompanies them. Vapefest, which started in 2010, is an annual show hosted by different cities. People attending these meetings are usually enthusiasts that use specialized, community-made products not found in convenience stores or gas stations. These products are mostly available online or in dedicated "vape" storefronts where mainstream e-cigarettes brands from the tobacco industry and larger e-cig manufacturers are not as popular. Some vape shops have a vape bar where patrons can test out different e-liquids and socialize. The Electronic Cigarette Convention in North America which started in 2013, is an annual show where companies and consumers meet up.
A subclass of vapers configure their atomizers to produce large amounts of vapor by using low-resistance heating coils. This practice is called "cloud-chasing". By using a coil with very low resistance, the batteries are stressed to a potentially unsafe extent. This could present a risk of dangerous battery failures. As vaping comes under increased scrutiny, some members of the vaping community have voiced their concerns about cloud-chasing, stating the practice gives vapers a bad reputation when doing it in public. The Oxford Dictionaries' word of the year for 2014 was "vape".
Regulation of e-cigarettes varies across countries and states, ranging from no regulation to banning them entirely. For instance, e-cigarettes are illegal in Japan, forcing the market to use heat-not-burn tobacco products for cigarette alternatives. Others have introduced strict restrictions and some have licensed devices as medicines such as in the UK. However, as of February 2018[update], there is no e-cigarette device that has been given a medical license that is commercially sold or available by prescription in the UK. As of 2015[update], around two thirds of major nations have regulated e-cigarettes in some way. Because of the potential relationship with tobacco laws and medical drug policies, e-cigarette legislation is being debated in many countries. The companies that make e-cigarettes have been pushing for laws that support their interests. In 2016 the US Department of Transportation banned the use of e-cigarettes on commercial flights. This regulation applies to all flights to and from the US. In 2018, the Royal College of Physicians asked that a balance is found in regulations over e-cigarettes that ensure product safety while encouraging smokers to use them instead of analogs, as well as keep an eye on any effects contrary to the control agencies for tobacco.
The legal status of e-cigarettes is currently pending in many countries. Many countries such as Brazil, Singapore, the Seychelles, and Uruguay have banned e-cigarettes. Canada-wide in 2014, they were technically illegal to sell, as no nicotine-containing e-cigarettes are not regulated by Health Canada, but this is generally unenforced and they are commonly available for sale Canada-wide. In 2016, Health Canada announced plans to regulate vaping products. In the US and the UK, the use and sale to adults of e-cigarettes are legal.:US:UK The revised EU Tobacco Products Directive came into effect May 2016, providing regulation for e-cigarettes. It limits e-cigarette advertising in print, on television and radio, along with reducing the level of nicotine in liquids and reducing the flavors used. It does not ban vaping in public places. It requires the purchaser for e-cigarettes to be at least 18 and does not permit buying them for anyone less than 18 years of age. The updated Tobacco Products Directive has been disputed by tobacco lobbyists whose businesses could be impacted by these revisions. As of August 8, 2016, the FDA extended its regulatory power to include e-cigarettes, e-liquid and all related products. Under this ruling the FDA will evaluate certain issues, including ingredients, product features and health risks, as well their appeal to minors and non-users. The FDA rule also bans access to minors. A photo ID is now required to buy e-cigarettes, and their sale in all-ages vending machines is not permitted in the US. As of August 2017, regulatory compliance deadlines relating to premarket review requirements for most e-cigarette and e-liquid products have been extended from November 2017 to August 8, 2022, which attracted a lawsuit filed by the American Heart Association, American Academy of Pediatrics, the Campaign for Tobacco-Free Kids, and other plaintiffs. In May 2016 the FDA used its authority under the Family Smoking Prevention and Tobacco Control Act to deem e-cigarette devices and e-liquids to be tobacco products, which meant it intended to regulate the marketing, labelling, and manufacture of devices and liquids; vape shops that mix e-liquids or make or modify devices were considered manufacturing sites that needed to register with FDA and comply with good manufacturing practice regulation. E-cigarette and tobacco companies have recruited lobbyists in an effort to prevent the FDA from evaluating e-cigarette products or banning existing products already on the market.
In February 2014 the European Parliament passed regulations requiring standardization and quality control for liquids and vaporizers, disclosure of ingredients in liquids, and child-proofing and tamper-proofing for liquid packaging. In April 2014 the FDA published proposed regulations for e-cigarettes. In the US some states tax e-cigarettes as tobacco products, and some state and regional governments have broadened their indoor smoking bans to include e-cigarettes. As of April 2017[update], 12 US states and 615 localities had prohibited the use of e-cigarettes in venues in which traditional cigarette smoking was prohibited. In 2015, at least 48 states and 2 territories had banned e-cigarette sales to minors.
E-cigarettes containing nicotine have been listed as drug delivery devices in a number of countries, and the marketing of such products has been restricted or put on hold until safety and efficacy clinical trials are conclusive. Since they do not contain tobacco, television advertising in the US is not restricted. Some countries have regulated e-cigarettes as a medical product even though they have not approved them as a smoking cessation aid. A 2014 review stated the emerging phenomenon of e-cigarettes has raised concerns in the health community, governments, and the general public and recommended that e-cigarettes should be regulated to protect consumers. It added, "heavy regulation by restricting access to e-cigarettes would just encourage continuing use of much unhealthier tobacco smoking." A 2014 review said regulation of the e-cigarette should be considered on the basis of reported adverse health effects.
A 2014 review said, "the e-cigarette companies have been rapidly expanding using aggressive marketing messages similar to those used to promote cigarettes in the 1950s and 1960s." E-cigarettes and nicotine are regularly promoted as safe and beneficial in the media and on brand websites, is an area of concern. While advertising of tobacco products is banned in most countries, television and radio e-cigarette advertising in several countries may be indirectly encouraging traditional cigarette smoking. There is no evidence that the cigarette brands are selling e-cigarettes as part of a plan to phase out traditional cigarettes, despite some claiming to want to cooperate in "harm reduction". In the US, six large e-cigarette businesses spent $59.3 million on promoting e-cigarettes in 2013. Easily circumvented age verification at company websites enables underage individuals to access and be exposed to marketing for e-cigarettes.
Celebrity endorsements are used to encourage e-cigarette use. A national US television advertising campaign starred Steven Dorff exhaling a "thick flume" of what the ad describes as "vapor, not tobacco smoke", exhorting smokers with the message "We are all adults here, it's time to take our freedom back." The ads, in a context of longstanding prohibition of tobacco advertising on TV, were criticized by organizations such as Campaign for Tobacco-Free Kids as undermining anti-tobacco efforts. Cynthia Hallett of Americans for Non-Smokers' Rights described the US advertising campaign as attempting to "re-establish a norm that smoking is okay, that smoking is glamorous and acceptable". University of Pennsylvania communications professor Joseph Cappella stated that the setting of the ad near an ocean was meant to suggest an association of clean air with the nicotine product.
E-cigarettes are aggressively promoted, mostly via the internet, as a healthy alternative to smoking. Tobacco companies intensely market e-cigarettes to youth, with industry strategies including cartoon characters and candy flavors. E-cigarette companies commonly promote that their products contain only water, nicotine, glycerin, propylene glycol, and flavoring but this assertion is misleading as researchers have found differing amounts of heavy metals in the vapor, including chromium, nickel, tin, silver, cadmium, mercury, and aluminum. The assertion that e-cigarettes emit "only water vapor" is false because the evidence indicates e-cigarette vapor contains possibly harmful chemicals such as nicotine, carbonyls, metals, and organic volatile compounds, in addition to particulates.
Vaping stand in London shopping centre.
The number of e-cigarettes sold increased every year from 2003 to 2014. In 2015 a slowdown in the growth in usage occurred in the US. As of January2018, the growth in usage in the UK has slowed down since 2013. As of 2014[update] there were at least 466 e-cigarette brands. Worldwide e-cigarette sales in 2014 were around US$7 billion. E-cigarette sales could exceed traditional cigarette sales by 2023. Approximately 30–50% of total e-cigarettes sales are handled on the internet. Established tobacco companies have a significant share of the e-cigarette market.
As of 2018[update] most e-cigarette devices were made in China, mainly in Shenzhen. Chinese companies' market share of e-liquid is low. In 2014, online and offline sales starting increases. Since combustible cigarettes are relatively inexpensive in China a lower price may not be large factor in marketing vaping products over there.
In 2015, 80% of all e-cigarette sales in convenience stores in the US were products made by tobacco companies. According to Nielsen Holdings, convenience store e-cigarette sales in the US went down for the first time during the four-week period ending on 10 May 2014. Wells Fargo analyst Bonnie Herzog attributes this decline to a shift in consumers' behavior, buying more specialized devices or what she calls "vapor/tank/mods (VTMs)" that are not tracked by Nielsen. Wells Fargo estimated that VTMs accounted for 57% of the 3.5 billion dollar market in the US for vapor products in 2015. In 2014, the Smoke-Free Alternatives Trade Association estimated that there were 35,000 vape shops in the US, more than triple the number a year earlier. However the 2015 slowdown in market growth affected VTMs as well. Large tobacco retailers are leading the cigalike market. "We saw the market's sudden recognition that the cigarette industry seems to be in serious trouble, disrupted by the rise of vaping," Mad Money's Jim Cramer stated April 2018. "Over the course of three short days, the tobacco stocks were bent, they were spindled and they were mutilated by the realization that electronic cigarettes have become a serious threat to the old-school cigarette makers," he added. The leading seller in the e-cigarette market in the US is the Juul e-cigarette, which was introduced in June 2015. As of August 2018[update], Juul accounts for over 72% of the US e-cigarette market monitored by Nielsen, and its closest competitor—RJ Reynolds' Vuse—makes up less than 10% of the market. Juul rose to popularity quickly, growing by 700% in 2016 alone. On July 17, 2018 Reynolds announced it will debut in August 2018 a "pod mod" type device similar Juul. The popularity of the Juul pod system has led to a flood of other pod devices hitting the market.
In Canada, e-cigarettes had an estimated value of 140 million CAD in 2015. There are numerous e-cigarette retail shops in Canada. A 2014 audit of retailers in four Canadian cities found that 94% of grocery stores, convenience stores, and tobacconist shops which sold e-cigarettes sold nicotine-free varieties only, while all vape shops stocked at least one nicotine-containing product.
By 2015 the e-cigarette market had only reached a twentieth of the size of the tobacco market in the UK. In the UK in 2015 the "most prominent brands of cigalikes" were owned by tobacco companies, however, with the exception of one model, all the tank types came from "non-tobacco industry companies". Yet some tobacco industry products, while using prefilled cartridges, resemble tank models.
France's e-cigarette market was estimated by Groupe Xerfi to be €130 million in 2015. Additionally, France's e-liquid market was estimated at €265 million. In December 2015, there were 2,400 vape shops in France, 400 fewer than in March of the same year. Industry organization Fivape said the reduction was due to consolidation, not to reduced demand.
An e-hookah user
Philip Morris International's IQOS device with charger and tobacco stick
Other devices to deliver inhaled nicotine have been developed. They aim to mimic the ritual and behavioral aspects of traditional cigarettes.
British American Tobacco, through their subsidiary Nicoventures, licensed a nicotine delivery system based on existing asthma inhaler technology from UK-based healthcare company Kind Consumer. In September 2014 a product based on this named Voke obtained approval from the United Kingdom's Medicines and Healthcare Products Regulatory Agency.
In 2011 Philip Morris International bought the rights to a nicotine pyruvate technology developed by Jed Rose at Duke University. The technology is based on the chemical reaction between pyruvic acid and nicotine, which produces an inhalable nicotine pyruvate vapor. Philip Morris Products S.A. created a different kind e-cigarette named P3L. The device is supplied with a cartridge that contains nicotine and lactic acid in different cavities. When turned on and heated, the nicotine salt called nicotine lactate forms an aerosol.
The IQOS is a heat-not-burn tobacco product marketed by Philip Morris International. It heats tobacco at a lower temperature than traditional cigarettes. The tobacco sticks reach a temperature up to 350 °C. It sold first in Japan since November 2014. On December 2, 2016, the United Tobacco Vapor Group's (UTVG) stated that they has been given a patent for their vaporizing component system. qmos from UTVG does not contain a wick or sponge and the number of components is 5 compared to 20 for traditional e-cigarettes.Pax Labs has developed vaporizers that heats the leaves of tobacco to deliver nicotine in a vapor. On June 1, 2015, they introduced Juul a type of e-cigarette which delivers 10 times as much nicotine as other e-cigarettes, equivalent to an actual cigarette puff. Juul was spun off from Pax Labs in June 2017 and is now available by the independent company Juul Labs. The eTron 3T from Vapor Tobacco Manufacturing, launched in December 2014, employs a patented, aqueous system whereby the tobacco is extracted into water. The e-liquid contains organic tobacco, organic glycerin, and water.
In December 2013 Japan Tobacco launched Ploom in Japan. In January 2016 they launched Ploom TECH that produces a vapor from a heated liquid that moves through a capsule of granulated tobacco leaves. In 2016 British American Tobacco (BAT) released its own version of the heat but not burn technology called glo in Japan and Switzerland. It uses tobacco sticks rather than nicotine liquid, and does not directly heat or burn tobacco. In 2015 the glo iFuse was released in Romania by BAT. It uses a coil to heat a liquid that produces a vapor that moves through mixed tobacco. Heat-not-burn tobacco products were first introduced in 1988, but were not a commercial success.
BLOW started selling e-hookahs, an electronic version of the hookah, in 2014. The handle of each hose for the e-hookah contains a heating element and a liquid, which produces vapor.Gopal Bhatnagar based in Toronto, Canada invented a 3D printed adapter to turn a traditional hookah into an e-hookah. It is used instead of the ceramic bowl that contains shisha tobacco. Rather than the tobacco, users can insert e-cigarettes. KanaVape is an e-cigarette containing cannabidiol (CBD) and no THC. Several companies including Canada's Eagle Energy Vapor are selling caffeine-based e-cigarettes instead of containing nicotine.
^A 2014 review found "In addition to the uniqueness of the liquid compositions in each brand, inconsistency of both the device performance properties and the data collection methodologies used by researchers contribute to the observed variation in constituent levels and to the range of particle size distributions among products."
^A 2012 review found "Whereas the "gateway" hypothesis does not specify mechanistic connections between "stages", and does not extend to the risks for addictions, the concept of common liability to addictions incorporates sequencing of drug use initiation as well as extends to related addictions and their severity, provides a parsimonious explanation of substance use and addiction co-occurrence, and establishes a theoretical and empirical foundation to research in etiology, quantitative risk and severity measurement, as well as targeted non-drug-specific prevention and early intervention."
^Since 2016 the US Food and Drug Administration (FDA) regulated e-cigarettes under the classification of tobacco products and labeled them as electronic nicotine delivery systems. A 2018 report commissioned by the FDA decided to use the term e-cigarettes, indicating that for some use e-liquids containing no nicotine.
^ abcdeAbrams, David B.; Glasser, Allison M.; Pearson, Jennifer L.; Villanti, Andrea C.; Collins, Lauren K.; Niaura, Raymond S. (2018). "Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives". Annual Review of Public Health. 39 (1): 193–213. doi:10.1146/annurev-publhealth-040617-013849. ISSN0163-7525. PMID29323611. This article incorporates text by David B. Abrams, Allison M. Glasser, Jennifer L. Pearson, Andrea C. Villanti, Lauren K. Collins, and Raymond S. Niaura available under the CC BY 4.0 license.
^ abcdefHildick-Smith, Gordon J.; Pesko, Michael F.; Shearer, Lee; Hughes, Jenna M.; Chang, Jane; Loughlin, Gerald M.; Ipp, Lisa S. (2015). "A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population". Journal of Adolescent Health. 57 (6): 574–9. doi:10.1016/j.jadohealth.2015.07.020. ISSN1054-139X. PMID26422289.
^ abcDrope, Jeffrey; Cahn, Zachary; Kennedy, Rosemary; Liber, Alex C.; Stoklosa, Michal; Henson, Rosemarie; Douglas, Clifford E.; Drope, Jacqui (2017). "Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine". CA: A Cancer Journal for Clinicians. 67 (6): 449–471. doi:10.3322/caac.21413. ISSN0007-9235. PMID28961314.
^ abcdefghijklmBhatnagar, A.; Whitsel, L. P.; Ribisl, K. M.; Bullen, C.; Chaloupka, F.; Piano, M. R.; Robertson, R. M.; McAuley, T.; Goff, D.; Benowitz, N. (24 August 2014). "Electronic Cigarettes: A Policy Statement From the American Heart Association". Circulation. 130 (16): 1418–1436. doi:10.1161/CIR.0000000000000107. PMID25156991.
^ abcdeSiu, AL (22 September 2015). "Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 163 (8): 622–34. doi:10.7326/M15-2023. PMID26389730.
^ abcdefghCahn, Z.; Siegel, M. (February 2011). "Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes?". Journal of Public Health Policy. 32 (1): 16–31. doi:10.1057/jphp.2010.41. PMID21150942.
^ abcCaponnetto, P.; Russo, C.; Bruno, C.M.; Alamo, A.; Amaradio, M.D.; Polosa, R. (March 2013). "Electronic cigarette: a possible substitute for cigarette dependence". Monaldi Archives for Chest Disease. 79 (1): 12–19. doi:10.4081/monaldi.2013.104. ISSN1122-0643. PMID23741941.
^ abBrady, Benjamin R.; De La Rosa, Jennifer S.; Nair, Uma S.; Leischow, Scott J. (2019). "Electronic Cigarette Policy Recommendations: A Scoping Review". American Journal of Health Behavior. 43 (1): 88–104. doi:10.5993/AJHB.43.1.8. ISSN1087-3244. PMID30522569.
^ abcBals, Robert; Boyd, Jeanette; Esposito, Susanna; Foronjy, Robert; Hiemstra, Pieter S.; Jiménez-Ruiz, Carlos A.; Katsaounou, Paraskevi; Lindberg, Anne; Metz, Carlos; Schober, Wolfgang; Spira, Avrum; Blasi, Francesco (2019). "Electronic cigarettes: a task force report from the European Respiratory Society". European Respiratory Journal. 53 (2): 1801151. doi:10.1183/13993003.01151-2018. ISSN0903-1936. PMID30464018.
^ abFernández, Esteve; Ballbè, Montse; Sureda, Xisca; Fu, Marcela; Saltó, Esteve; Martínez-Sánchez, Jose M. (2015). "Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study". Current Environmental Health Reports. 2 (4): 423–9. doi:10.1007/s40572-015-0072-x. ISSN2196-5412. PMID26452675.
^ abcdSchraufnagel, Dean E.; Blasi, Francesco; Drummond, M. Bradley; Lam, David C. L.; Latif, Ehsan; Rosen, Mark J.; Sansores, Raul; Van Zyl-Smit, Richard (2014). "Electronic Cigarettes. A Position Statement of the Forum of International Respiratory Societies". American Journal of Respiratory and Critical Care Medicine. 190 (6): 611–618. doi:10.1164/rccm.201407-1198PP. ISSN1073-449X. PMID25006874.
^ abTomashefski, A (21 March 2016). "The perceived effects of electronic cigarettes on health by adult users: A state of the science systematic literature review". Journal of the American Association of Nurse Practitioners. 28 (9): 510–515. doi:10.1002/2327-6924.12358. PMID26997487.
^Serror, K.; Chaouat, M.; Legrand, Matthieu M.; Depret, F.; Haddad, J.; Malca, N.; Mimoun, M.; Boccara, D. (2018). "Burns caused by electronic vaping devices (e-cigarettes): A new classification proposal based on mechanisms". Burns. 44 (3): 544–548. doi:10.1016/j.burns.2017.09.005. ISSN0305-4179. PMID29056367.
^ abRinkoo, ArvindVashishta; Kaur, Jagdish (2017). "Getting real with the upcoming challenge of electronic nicotine delivery systems: The way forward for the South-East Asia region". Indian Journal of Public Health. 61 (5): S7–S11. doi:10.4103/ijph.IJPH_240_17. ISSN0019-557X. PMID28928312.
^Fadus, Matthew C.; Smith, Tracy T.; Squeglia, Lindsay M. (2019). "The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects". Drug and Alcohol Dependence. 201: 85–93. doi:10.1016/j.drugalcdep.2019.04.011. ISSN0376-8716. PMID31200279.
^ abStratton 2018, p. Conceptual Framework: Patterns of Use Among Youth and Young Adults; 497.
^ abHefner, Kathryn; Valentine, Gerald; Sofuoglu, Mehmet (2017). "Electronic cigarettes and mental illness: Reviewing the evidence for help and harm among those with psychiatric and substance use disorders". The American Journal on Addictions. 26 (4): 306–315. doi:10.1111/ajad.12504. ISSN1055-0496. PMID28152247. This article incorporates text from this source, which is in the public domain.
^ abDautzenberg, B.; Adler, M.; Garelik, D.; Loubrieu, J.F.; Mathern, G.; Peiffer, G.; Perriot, J.; Rouquet, R.M.; Schmitt, A.; Underner, M.; Urban, T. (2017). "Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement". Revue des Maladies Respiratoires. 34 (2): 155–164. doi:10.1016/j.rmr.2017.01.001. ISSN0761-8425. PMID28189437.
^Stratton 2018, p. Conceptual Framework: Patterns of Use Among Youth and Young Adults; 531.
^ abSchneider, Sven; Diehl, Katharina (2016). "Vaping as a Catalyst for Smoking? An Initial Model on the Initiation of Electronic Cigarette Use and the Transition to Tobacco Smoking Among Adolescents". Nicotine & Tobacco Research. 18 (5): 647–653. doi:10.1093/ntr/ntv193. ISSN1462-2203. PMID26386472.
^Yoong, Sze Lin; Stockings, Emily; Chai, Li Kheng; Tzelepis, Flora; Wiggers, John; Oldmeadow, Christopher; Paul, Christine; Peruga, Armando; Kingsland, Melanie; Attia, John; Wolfenden, Luke (2018). "Prevalence of electronic nicotine delivery systems (ENDS) use among youth globally: a systematic review and meta-analysis of country level data". Australian and New Zealand Journal of Public Health. 42 (3): 303–308. doi:10.1111/1753-6405.12777. ISSN1326-0200. PMID29528527.
^ abcChatterjee, Kshitij; Alzghoul, Bashar; Innabi, Ayoub; Meena, Nikhil (2016). "Is vaping a gateway to smoking: a review of the longitudinal studies". International Journal of Adolescent Medicine and Health. 0 (3). doi:10.1515/ijamh-2016-0033. ISSN2191-0278. PMID27505084.
^Singh, Tushar; Marynak, Kristy; Arrazola, René A.; Cox, Shanna; Rolle, Italia V.; King, Brian A. (2016). "Vital Signs: Exposure to Electronic Cigarette Advertising Among Middle School and High School Students — United States, 2014". MMWR. Morbidity and Mortality Weekly Report. 64 (52): 1403–1408. doi:10.15585/mmwr.mm6452a3. ISSN0149-2195. PMID26741522.
^ abCrowley, Ryan A. (2015). "Electronic Nicotine Delivery Systems: Executive Summary of a Policy Position Paper From the American College of Physicians". Annals of Internal Medicine. 162 (8): 583–4. doi:10.7326/M14-2481. ISSN0003-4819. PMID25894027.
^Jankowski, Mateusz; Brożek, Grzegorz; Lawson, Joshua; Skoczyński, Szymon; Zejda, Jan (2017). "E-smoking: Emerging public health problem?". International Journal of Occupational Medicine and Environmental Health. 30 (3): 329–344. doi:10.13075/ijomeh.1896.01046. ISSN1232-1087. PMID28481369.
^Jimenez Ruiz, CA; Solano Reina, S; de Granda Orive, JI; Signes-Costa Minaya, J; de Higes Martinez, E; Riesco Miranda, JA; Altet Gómez, N; Lorza Blasco, JJ; Barrueco Ferrero, M; de Lucas Ramos, P (August 2014). "The electronic cigarette. Official statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the efficacy, safety and regulation of electronic cigarettes". Archivos de Bronconeumologia. 50 (8): 362–7. doi:10.1016/j.arbres.2014.02.006. PMID24684764.
^Gualano, Maria Rosaria; Passi, Stefano; Bert, Fabrizio; La Torre, Giuseppe; Scaioli, Giacomo; Siliquini, Roberta (September 2015). "Electronic cigarettes: assessing the efficacy and the adverse effects through a systematic review of published studies". Journal of Public Health. 37 (3): 488–497. doi:10.1093/pubmed/fdu055. PMID25108741.
^ abcOrellana-Barrios MA, Payne D, Medrano-Juarez RM, Yang S, Nugent K (2016). "Electronic Cigarettes for Smoking Cessation". The American Journal of the Medical Sciences. 52 (4): 420–426. doi:10.1016/j.amjms.2016.07.013. PMID27776725.CS1 maint: Multiple names: authors list (link)
^ abcKhoudigian, S.; Devji, T.; Lytvyn, L.; Campbell, K.; Hopkins, R.; O'Reilly, D. (29 January 2016). "The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis". International Journal of Public Health. 61 (2): 257–267. doi:10.1007/s00038-016-0786-z. ISSN1661-8556. PMID26825455.
^Villanti, Andrea C.; Feirman, Shari P.; Niaura, Raymond S.; Pearson, Jennifer L.; Glasser, Allison M.; Collins, Lauren K.; Abrams, David B. (2018). "How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor". Addiction. 113 (3): 391–404. doi:10.1111/add.14020. ISSN0965-2140. PMID28975720.
^ abMalas, Muhannad; van der Tempel, Jan; Schwartz, Robert; Minichiello, Alexa; Lightfoot, Clayton; Noormohamed, Aliya; Andrews, Jaklyn; Zawertailo, Laurie; Ferrence, Roberta (25 April 2016). "Electronic Cigarettes for Smoking Cessation: A Systematic Review". Nicotine & Tobacco Research. 18 (10): 1926–1936. doi:10.1093/ntr/ntw119. ISSN1462-2203. PMID27113014.
^Vanderkam, Paul; Boussageon, Rémy; Underner, Michel; Langbourg, Nicolas; Brabant, Yann; Binder, Philippe; Freche, Bernard; Jaafari, Nematollah (2016). "Efficacité et sécurité de la cigarette électronique pour la réduction du tabagisme : revue systématique et méta-analyse". La Presse Médicale. 45 (11): 971–985. doi:10.1016/j.lpm.2016.05.026. ISSN0755-4982. PMID27597300.
^Coleman, Tim; Chamberlain, Catherine; Davey, Mary-Ann; Cooper, Sue E; Leonardi-Bee, Jo; Coleman, Tim (2015). "Pharmacological interventions for promoting smoking cessation during pregnancy". The Cochrane Database of Systematic Reviews (12): CD010078. doi:10.1002/14651858.CD010078.pub2. PMID26690977.
^ abFranks, Andrea S; Sando, Karen; McBane, Sarah (2018). "Do Electronic Cigarettes Have a Role in Tobacco Cessation?". Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 38 (5): 555–568. doi:10.1002/phar.2103. ISSN0277-0008. PMID29573440.
^Gentry, Sarah; Forouhi, Nita; Notley, Caitlin (2018). "Are Electronic Cigarettes an Effective Aid to Smoking Cessation or Reduction Among Vulnerable Groups? A Systematic Review of Quantitative and Qualitative Evidence". Nicotine & Tobacco Research. 21 (5): 602–616. doi:10.1093/ntr/nty054. ISSN1462-2203. PMID29608714.
^Ferkol, Thomas W.; Farber, Harold J.; La Grutta, Stefania; Leone, Frank T.; Marshall, Henry M.; Neptune, Enid; Pisinger, Charlotta; Vanker, Aneesa; Wisotzky, Myra; Zabert, Gustavo E.; Schraufnagel, Dean E. (2018). "Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies". European Respiratory Journal. 51 (5): 1800278. doi:10.1183/13993003.00278-2018. ISSN0903-1936. PMID29848575.
^Scherer, Gerhard (2018). "Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review". Regulatory Toxicology and Pharmacology. 94: 203–233. doi:10.1016/j.yrtph.2018.02.002. ISSN0273-2300. PMID29428304.
^Hess, IM; Lachireddy, K; Capon, A (15 April 2016). "A systematic review of the health risks from passive exposure to electronic cigarette vapour". Public Health Research & Practice. 26 (2). doi:10.17061/phrp2621617. PMID27734060.
^ abcdeKorpi, E. R.; den Hollander, B.; Farooq, U.; Vashchinkina, E.; Rajkumar, R.; Nutt, D. J.; Hyytia, P.; Dawe, G. S. (2015). "Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse". Pharmacological Reviews. 67 (4): 872–1004. doi:10.1124/pr.115.010967. ISSN1521-0081. PMID26403687.
^Laura J. Martin, David Zieve, Isla Ogilvie, A.D.A.M. Editorial team (7 June 2016). "Nicotine and Tobacco". Medline Plus.CS1 maint: Uses authors parameter (link)
^ ab"Nicotine". National Institute on Drug Abuse. June 2007. This article incorporates text from this source, which is in the public domain.
^Shahab, Lion; Brose, Leonie S.; West, Robert (2013). "Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems". CNS Drugs. 27 (12): 1007–1019. doi:10.1007/s40263-013-0116-4. ISSN1172-7047. PMID24114587.
^ abSingh, Tushar; Arrazola, René A.; Corey, Catherine G.; Husten, Corinne G.; Neff, Linda J.; Homa, David M.; King, Brian A. (2016). "Tobacco Use Among Middle and High School Students — United States, 2011–2015". MMWR. Morbidity and Mortality Weekly Report. 65 (14): 361–367. doi:10.15585/mmwr.mm6514a1. ISSN0149-2195. PMID27077789.
^Cervellin, Gianfranco; Borghi, Loris; Mattiuzzi, Camilla; Meschi, Tiziana; Favaloro, Emmanuel; Lippi, Giuseppe (2013). "E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism". Seminars in Thrombosis and Hemostasis. 40 (1): 060–065. doi:10.1055/s-0033-1363468. ISSN0094-6176. PMID24343348.
^Maloney, Erin K.; Cappella, Joseph N. (2015). "Does Vaping in E-Cigarette Advertisements Affect Tobacco Smoking Urge, Intentions, and Perceptions in Daily, Intermittent, and Former Smokers?". Health Communication. 31 (1): 1–10. doi:10.1080/10410236.2014.993496. ISSN1041-0236. PMID25758192.
^Wasowicz A., Feleszko W., Goniewicz M.L. (2015). "E-Cigarette use among children and young people: the need for regulation". Expert Rev Respir Med. 9 (5): 1–3. doi:10.1586/17476348.2015.1077120. PMID26290119.CS1 maint: Uses authors parameter (link)
^Fernández, Esteve; Ballbè, Montse; Sureda, Xisca; Fu, Marcela; Saltó, Esteve; Martínez-Sánchez, Jose M. (2015). "Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study". Current Environmental Health Reports. 2 (4): 423–9. doi:10.1007/s40572-015-0072-x. ISSN2196-5412. PMID26452675.